Literature DB >> 8224012

Cytotoxic activity of rev protein of human immunodeficiency virus type 1 by nucleolar dysfunction.

T Nosaka1, T Takamatsu, Y Miyazaki, K Sano, A Sato, S Kubota, M Sakurai, Y Ariumi, M Nakai, S Fujita.   

Abstract

The rev protein (Rev) of the human immunodeficiency virus type 1 (HIV-1) is known as a post-transcriptional regulator of viral gene expression. It is located in the cell nucleolus. Transiently expressed Rev caused nucleolar ballooning and deformity with aberrant accumulation of rRNAs, and de novo synthesis of rRNAs decreased dramatically in these cells. However, similarly expressed rex protein (Rex) of the human T-cell leukemia virus type I, which is a functional homologue to Rev, did not affect nucleolar structure and function. Rev expression resulted in cell death with nucleolar destruction in an inducible cell line. Analysis of Rev mutants revealed that both the nucleolar targeting signal of Rev and the multimerization domain are prerequisites to the nucleolar disintegration by Rev. Human T-cells acutely infected with HIV-1 contained nucleoli which were deformed and filled with Rev, but chronically infected cells had intact nucleoli. Involvement of Rev in cytopathic effects in HIV-1 infection is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224012     DOI: 10.1006/excr.1993.1289

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element.

Authors:  S B Buonomo; A Michienzi; F G De Angelis; I Bozzoni
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

2.  Nucleoplasmic and nucleolar distribution of the adenovirus IVa2 gene product.

Authors:  P Lutz; F Puvion-Dutilleul; Y Lutz; C Kedinger
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter.

Authors:  P Lutz; C Kedinger
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein.

Authors:  S Kubota; L Duan; R A Furuta; M Hatanaka; R J Pomerantz
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.

Authors:  R A Furuta; S Kubota; M Maki; Y Miyazaki; T Hattori; M Hatanaka
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

6.  Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.

Authors:  Janet Chung; Jane Zhang; Haitang Li; Dominique L Ouellet; David L DiGiusto; John J Rossi
Journal:  Hum Gene Ther       Date:  2012-09-18       Impact factor: 5.695

7.  The bovine immunodeficiency virus rev protein: identification of a novel lentiviral bipartite nuclear localization signal harboring an atypical spacer sequence.

Authors:  Andrea Gomez Corredor; Denis Archambault
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

8.  Localization of HIV-1 RNA in mammalian nuclei.

Authors:  G Zhang; M L Zapp; G Yan; M R Green
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.